Immuno-Oncology Panel Session
We’ve all heard the axiom, “Start with the end in mind.’” For decades, this approach has driven breakthroughs in the biopharmaceutical industry. However, at times we need to take a moment and reflect on how far we have come and where innovation is leading us. With that in mind, Kineticos recently tapped 3 industry veterans and oncology experts to lead a panel discussion on the Immuno-Oncology landscape and what the future holds.
- Chris Heery – Chief Medical Officer, Bavarian Nordic
- Jeff Kmetz – Former Chief Business Officer, Pulse Biosciences
- Alex Dusek – Vice President of Commercial Strategy, Erytech (To be featured in Parts 2-4)
Click here for a condensed and edited version of Part 1.
Subscribe to Kineticos and receive more insightful content.